We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAY icon
176
Accuray
ARAY
$31.9M
$1.48M 0.02%
5,736,000
+100,000
+2% +$37.2K
SFIX
177
Stitch Fix
SFIX
$407M
$1.45M 0.02%
352,776
+315,254
+840% +$1.15M
NGEN
178
NervGen Pharma
NGEN
$251M
$1.4M 0.02%
+678,000
New +$2.1M
TXRH icon
179
Texas Roadhouse
TXRH
$12.4B
$1.36M 0.02%
+7,029
New +$1.2M
FIGS icon
180
FIGS
FIGS
$2.4B
$1.33M 0.02%
+129,830
New +$1.71M
SHOP icon
181
Shopify
SHOP
$187B
$1.25M 0.02%
+10,971
New +$1.25M
BURL icon
182
Burlington
BURL
$16.7B
$1.25M 0.02%
+3,930
New +$1.27M
KSS icon
183
Kohl's
KSS
$2.2B
$1.22M 0.01%
+68,582
New +$1.02M
DVN icon
184
Devon Energy
DVN
$52.9B
$1.14M 0.01%
+27,556
New +$1.28M
SHOO icon
185
Steven Madden
SHOO
$3.2B
$1.12M 0.01%
+26,613
New +$1.08M
SITM icon
186
SiTime
SITM
$18.4B
$1.05M 0.01%
+1,408
New +$888K
TGT icon
187
Target
TGT
$74.7B
$1.01M 0.01%
+7,701
New +$978K
STUB
188
StubHub Holdings
STUB
$2.52B
$958K 0.01%
+74,410
New +$657K
BJRI icon
189
BJ's Restaurants
BJRI
$1.27B
$951K 0.01%
+15,666
New +$685K
BLCO icon
190
Bausch + Lomb
BLCO
$6.44B
$878K 0.01%
+53,000
New +$843K
MTZ icon
191
MasTec
MTZ
$19B
$875K 0.01%
+2,104
New +$804K
NTRP icon
192
NextTrip
NTRP
$21.3M
$860K 0.01%
402,081
-273,036
-40% -$694K
AVB
193
DELISTED
AvalonBay Communities
AVB
$834K 0.01%
+4,420
New +$799K
MAT icon
194
Mattel
MAT
$4.15B
$817K 0.01%
+58,871
New +$861K
FWRG icon
195
First Watch Restaurant Group
FWRG
$744M
$764K 0.01%
59,278
+48,044
+428% +$564K
DNUT icon
196
Krispy Kreme
DNUT
$586M
$763K 0.01%
+216,138
New +$772K
AFL icon
197
Aflac
AFL
$58.8B
$748K 0.01%
+6,378
New +$734K
CODX
198
Co-Diagnostics
CODX
$8.1M
$732K 0.01%
+236,000
New +$726K
VIK icon
199
Viking Holdings
VIK
$38.3B
$716K 0.01%
+6,836
New +$591K
DG icon
200
Dollar General
DG
$29.4B
$709K 0.01%
+6,162
New +$700K
6 7
8
9 10

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.